Luisa Bonilla

Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2

Linh T. Nguyen, Samuel D. Saibil, Valentin Sotov et al. · Cancer Immunology Immunotherapy · 2019 · 132 citations · Full text

Fatal Myocarditis and Rhabdomyositis in a Patient with Stage Iv Melanoma Treated with Combined Ipilimumab and Nivolumab

Samuel D. Saibil, Luisa Bonilla, H. Majeed et al. · Current Oncology · 2019 · 37 citations · Full text

Fatal Myocarditis, Immunology, Pathology +16

Different Schedules of Granulocyte Growth Factor Support for Patients With Breast Cancer Receiving Adjuvant Dose-Dense Chemotherapy

Daniel Hendler, Shulamith Rizel, Rinat Yerushalmi et al. · American Journal of Clinical Oncology · 2011 · 22 citations

Evolve: A post PARP inhibitor clinical translational phase II trial of cediranib-olaparib in ovarian cancer—A Princess Margaret Consortium – GCIG Phase II Trial.

Stéphanie Lheureux, Ana Oaknin, Swati Garg et al. · Journal of Clinical Oncology · 2019 · 14 citations

Medicine, Cancer Management, Metronomic Therapy +15

Adoptive T cell therapy with TBI-1301 results in gene-engineered T cell persistence and anti-tumour responses in patients with NY-ESO-1 expressing solid tumours

Marcus O. Butler, Valentin Sotov, Samuel D. Saibil et al. · Annals of Oncology · 2019 · 10 citations · Full text

Tbi-1301 Results, Cell Therapy, Medicine +9